4d Pharma PLC Appointment of Joint Broker (3241F)
February 20 2018 - 2:01AM
UK Regulatory
TIDMDDDD
RNS Number : 3241F
4d Pharma PLC
20 February 2018
4D pharma plc
(the "Company" or "4D")
Appointment of Joint Broker
4D pharma plc (AIM: DDDD), a pharmaceutical company focusing on
the development of live biotherapeutics, announces that it has with
immediate effect appointed Bryan Garnier & Co. Limited as its
joint corporate broker, to act alongside Zeus Capital Limited who
remain the Company's Nominated Adviser and joint corporate
broker.
For further information please contact:
4D + 44 (0)113 895 0130
Duncan Peyton, Chief Executive Officer
Zeus Capital Limited - Nomad and Joint Broker
Dan Bate / Jordan Warburton +44 (0) 161 831 1512
Hugh Kingsmill Moore +44 (0) 203 829 5000
Bryan Garnier & Co. Limited - Joint Broker +44 (0)20 7332 2500
Dominic Wilson
Phil Walker
About 4D
Founded in February 2014, 4D is a world leader in the
development of live biotherapeutics, a novel and emerging class of
drugs, defined by the FDA as biological products that contain a
live organism, such as a bacteria, that is applicable to the
prevention, treatment or cure of a disease. 4D has developed a
proprietary platform, MicroRx, that rationally identifies novel
bacteria that have a precise and evolved therapeutic effect. All of
4D's live biotherapeutic products are orally delivered single
strains of bacteria that are naturally found in the healthy human
gut. 4D currently has a pipeline of 13 preclinical programmes,
covering disease areas such as rheumatoid arthritis, multiple
sclerosis and cancer, and is currently conducting subject trials in
Irritable Bowel Syndrome and Paediatric Crohn's Disease. The
programmes in Paediatric Ulcerative Colitis and Paediatric Crohn's
Disease have both been granted Orphan Drug Status by the FDA.
This information is provided by RNS
The company news service from the London Stock Exchange
END
APPTLMPTMBTBBTP
(END) Dow Jones Newswires
February 20, 2018 02:01 ET (07:01 GMT)
4d Pharma (LSE:DDDD)
Historical Stock Chart
From Apr 2024 to May 2024
4d Pharma (LSE:DDDD)
Historical Stock Chart
From May 2023 to May 2024
